A groundbreaking discovery from Chhattisgarh suggests that a specific type of rice could revolutionize cancer treatment. The Indira Gandhi Agricultural University in Raipur has been researching a nearly extinct rice variety from the Bastar region, named Sanjeevani, and found it to have cancer-fighting properties. The research, conducted in collaboration with the Bhabha Atomic Research Centre, revealed that this rice contains compounds that can effectively eliminate cancer cells. Studies on mice have demonstrated remarkable results, further corroborated by the Central Drug Research Institute. Human trials for Sanjeevani rice are planned at the Tata Memorial Cancer Hospital, starting in January. This unique rice variety boasts 213 biochemicals, with seven specifically identified as having anti-cancer effects. These compounds are believed to activate the NRF2 pathway, which helps to protect the body from cell damage that can lead to cancer. The recommended dosage is 10 grams of Sanjeevani rice for ten days to potentially strengthen immunity. This discovery marks a significant step forward in medicine, potentially offering a medicinal use for rice. Experts anticipate that this rice could be used medicinally in the next two to three years. Dr. Deepak Sharma highlights that this research is a testament to the foresight of Dr. R. H. Richharia, who, in 1974, envisioned the therapeutic potential of rice.